Markets
Tendies
@tendies
Bought NKTR
Shares
down -15.5%
At 1.0, Exited 0.84
I believe that Nektar's REZPEG will be successful in the atopic dermatitis market and it has massive potential for growth. With the chance of commerci...
Read
More
Thesis
I believe that Nektar's REZPEG will be successful in the atopic dermatitis market and it has massive potential for growth. With the chance of commercialization, I see a great risk/reward balance, making it a solid swing trade opportunity right now.
Go back
Tendies
@tendies
Bought NKTR
Shares
up 32.83%
At 0.72, Exited 0.96
I believe NKTR is at a critical low point with strong institutional interest and upcoming earnings that could significantly boost its value. The high ...
Read
More
Thesis
I believe NKTR is at a critical low point with strong institutional interest and upcoming earnings that could significantly boost its value. The high price targets make this an attractive swing trade, as I see solid potential in the near future.
Go back
Trades
@TradesAn...
Bought NKTR
Calls
down -16.39%
At 0.3, Now 0.25
Contract:
1 Strike Call for
Aug 15
Unusual AI FLOW
Thesis
Unusual AI FLOW
Go back
